ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

0QQ6 Roche Holding Ag

229.20
0.00 (0.00%)
2024年4月26日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Roche Holding Ag 0QQ6 ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
0.00 0.00% 229.20 09:00:00
始値 安値 高値 終値 前日終値
229.20 229.20
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2414:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales..
2024/4/2414:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der..
2024/4/1914:00UKREGFDA approves Roche’s Alecensa as the first adjuvant..
2024/4/1715:00UKREGRoche’s subcutaneous OCREVUS one-year data demonstrates..
2024/4/1514:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi..
2024/4/1114:00UKREGRoche granted FDA Breakthrough Device Designation for blood..
2024/3/2701:45UKREGRoche receives FDA approval for the first molecular test to..
2024/3/1221:30UKREGRoche Annual General Meeting 2024
2024/3/1221:30UKREGAssemblée générale 2024 de Roche
2024/3/1221:30UKREGRoche Generalversammlung 2024
2024/3/0521:30UKREGRoche and Alnylam report positive topline results from the..
2024/2/2604:00UKREGNew England Journal of Medicine publishes Phase III data..
2024/2/1701:24UKREGFDA approves Xolair as first and only medicine for children..
2024/2/0115:03UKREGNew long-term data for Roche’s Vabysmo show sustained..
2024/2/0115:00UKREG[Annonce événementielle au sens de l’art. 53 RC] Roche..
2024/2/0115:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds..
2024/2/0115:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft..
2024/1/1615:00GLOBEEuropean Commission approves Roche’s Tecentriq SC, the EU's..
2023/12/3006:30GLOBERoche enters into a definitive agreement to acquire..
2023/12/1923:40GLOBEFDA grants priority review to Xolair (omalizumab) for..
2023/12/1515:15GLOBERoche named among top three most sustainable healthcare..
2023/12/1115:00GLOBENew data for Roche’s Columvi and Lunsumio presented at ASH..
2023/12/1001:30GLOBENew data reinforce the benefit of early preventative..
2023/12/0901:50GLOBERoche's Kadcyla is the first targeted therapy to show..
2023/12/0901:45GLOBERoche’s inavolisib combination reduces the risk of disease..
2023/12/0515:00GLOBERoche announces positive Phase III results for inavolisib..
2023/12/0415:00GLOBERoche enters into a definitive merger agreement to acquire..
2023/11/2715:00GLOBERoche expands hepatitis diagnostics portfolio to help..
2023/11/1615:00GLOBERoche launches automated serology hepatitis E virus tests,..
2023/11/1415:00GLOBERoche’s subcutaneous injection of Tecentriq recommended by..
2023/11/0915:00GLOBERoche’s Elecsys NfL test, an important aid for those living..
2023/10/3105:01GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche announces..
2023/10/2714:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] FDA approves..
2023/10/2320:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
2023/10/2314:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche enters..
2023/10/1914:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit gutem..
2023/10/1814:03GLOBERoche IL-6 is the first immunoassay approved to aid sepsis..
2023/10/1814:00GLOBERoche’s Alecensa reduces the risk of disease recurrence or..
2023/10/1322:30GLOBELate-breaking data for Roche’s BTK inhibitor fenebrutinib..
2023/10/1214:00GLOBENew data for Roche’s OCREVUS show that after 10 years of..
2023/10/1115:00GLOBERoche’s OCREVUS twice-yearly, 10-minute subcutaneous..
2023/10/1014:00GLOBERoche’s Vabysmo maintained vision improvements with extended..
2023/10/0414:00GLOBEMajority of newborn babies with spinal muscular atrophy..
2023/10/0214:00GLOBERoche to present new key clinical and real-world data at..
2023/9/0720:00GLOBERoche and Alnylam report positive topline results from Phase..
2023/9/0114:00GLOBERoche’s Alecensa delivers unprecedented Phase III results..
2023/8/2918:00GLOBERoche’s Tecentriq becomes the first subcutaneous..
2023/8/2914:00GLOBEEuropean Commission approves Roche’s Evrysdi for babies..
2023/8/2314:22GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche provides..
2023/7/2714:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche verzeichnet..

最近閲覧した銘柄

Delayed Upgrade Clock